HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy.

HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy.

Item
http://www.wikidata.org/entity/Q45254374
Clinicopathologic, mammographic, and sonographic features in 1,187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status.Enhanced resistance to tamoxifen by the c-ABL proto-oncogene in breast cancer.Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review.Role of ERRF, a novel ER-related nuclear factor, in the growth control of ER-positive human breast cancer cellsSERPINA1 is a direct estrogen receptor target gene and a predictor of survival in breast cancer patients.Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancerBasal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ.Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies.Developing in vitro models of human ductal carcinoma in situ from primary tissue explants.Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer.Single-cell heterogeneity in ductal carcinoma in situ of breast.
P2860

HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy.

Item
http://www.wikidata.org/entity/Q45254374
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
HER2 protein overexpression in ...... cations for tamoxifen therapy.
@en
HER2 protein overexpression in ...... cations for tamoxifen therapy.
@nl
type
label
HER2 protein overexpression in ...... cations for tamoxifen therapy.
@en
HER2 protein overexpression in ...... cations for tamoxifen therapy.
@nl
prefLabel
HER2 protein overexpression in ...... cations for tamoxifen therapy.
@en
HER2 protein overexpression in ...... cations for tamoxifen therapy.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P921
P356
P1433
P1476
HER2 protein overexpression in ...... cations for tamoxifen therapy.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P6179
P698
P921